Trends in Anti-Vascular Endothelial Growth Factor Agents and Panretinal Photocoagulation Use in Diabetic Retinopathy

被引：0

作者：

Azad, Amee D. ^{[1
]}

Chen, Evan M. ^{[2
]}

Hinkle, John ^{[1
]}

Rayess, Nadim ^{[1
]}

Wu, David ^{[3
]}

Eliott, Dean ^{[4
,5
]}

Mruthyunjaya, Prithvi ^{[1
]}

Parikh, Ravi ^{[4
,5
,6
]}

机构：

[1] Stanford Univ, Sch Med, Dept Ophthalmol, Byers Eye Inst, 2452 Watson Court, Palo Alto, CA 94304 USA

[2] Yale Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT USA

[3] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA

[4] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA

[5] Massachusetts Eye & Ear, Retina Serv, Boston, MA USA

[6] Manhattan Retina & Eye Consultants, New York, NY USA

来源：

OPHTHALMOLOGY RETINA | 2021年 / 5卷 / 04期

关键词：

Anti-vascular endothelial growth factor; Diabetic macular edema; Panretinal photocoagulation; Proliferative diabetic retinopathy; RANIBIZUMAB;

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：390 / 392

页数：4

共 50 条

[31] Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions
Wubben, Thomas J.
Johnson, Mark W.
Sohn, Elliott H.
Peairs, James J.
Kay, Christine N.
Kim, Stephen J.
Gardner, Thomas W.
Paulus, Yannis M.
Zacks, David N.
Steinle, Nathan C.
Avery, Robert L.
Berrocal, Maria H.
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 204 : 13 - 18
[32] Anti-Vascular Endothelial Growth Factor Injections for Diabetic Retinopathy: Continued Progress, More Questions
Frank, Robert N.
OPHTHALMOLOGY, 2019, 126 (05) : 721 - 722
[33] Anti-vascular endothelial growth factor for diabetic macular oedema
Virgili, Gianni
Parravano, Mariacristina
Menchini, Francesca
Evans, Jennifer R.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10):
[34] INTRAOCULAR PRESSURE TRENDS AFTER INTRAVITREAL INJECTIONS OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS FOR DIABETIC MACULAR EDEMA
Al-Abdullah, Abdulelah A.
Nowilaty, Sawsan R.
Asghar, Nasira
Al-Kharashi, Abdullah S. A.
Ghazi, Nicola G.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (03): : 440 - 448
[35] Update on Anti-Vascular Endothelial Growth Factor Safety for Retinopathy of Prematurity
Enriquez, Ana Bety
Avery, Robert L.
Baumal, Caroline R.
ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2020, 9 (04): : 358 - 368
[36] Anti-vascular endothelial growth factor intravitreal therapy for retinopathy of prematurity
VanderVeen, Deborah K.
Cataltepe, Sule U.
SEMINARS IN PERINATOLOGY, 2019, 43 (06) : 375 - 380
[37] Anti-vascular endothelial growth factor bevacizumab (Avastin) for radiation retinopathy
Finger, Paul T.
Chin, Kimberly
ARCHIVES OF OPHTHALMOLOGY, 2007, 125 (06) : 751 - 756
[38] Retinopathy of Prematurity: Evolving Treatment With Anti-Vascular Endothelial Growth Factor
Hartnett, M. Elizabeth
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2020, 218 : 208 - 213
[39] Anti-vascular endothelial growth factor (anti-VEGF) compared with laser photocoagulation for the treatment of retinopathy of prematurity type 1
Gonzalez C, Raul
Diaz C, Marcela
Garreton C, Rodolfo
MEDWAVE, 2022, 22 (01):
[40] Current perspectives on use of anti-vascular endothelial growth factor agents for retinal disorders
Sengupta, Sabyasachi
INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (02) : 209 - 210

← 1 2 3 4 5 →